Search

everythinglearnresearchcommunity

for

Search:↓

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Eating healthy, exercising, and taking certain supplements can help manage Polycystic Ovary Syndrome symptoms.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.